Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yifan Jia has a total of 60 co-authors. Here are the top co-authors by number of shared publications:

  • Ming Zhang

    Center for Coronary Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

    8 shared publications
  • Yu Ning

    Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

    6 shared publications
  • Yunxiao Yang

    Department of Cardiology Beijing Anzhen Hospital, Capital Medical University Beijing China

    5 shared publications
  • Mengling Huang

    Department of Cardiology Beijing Anzhen Hospital, Capital Medical University Beijing China

    4 shared publications
  • Wanwan Wen

    Department of Cardiology Beijing Anzhen Hospital, Capital Medical University Beijing China

    4 shared publications
  • Yongxiang Wei

    Department of Otolaryngology, Smell and Taste Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

    4 shared publications

Latest Publications

  • Open Access

    High-Density and Resolution Epicardial Mapping of the Atria: Translational Research with Clinical Impact

    by Ziliang Ye, Yifan Jia, Mathijs S. van Schie, Paul Knops, Vehpi Yildirim, Yannick J. H. J. Taverne, Natasja M. S. de Groot

    The electrical arrhythmogenic substrate underlying the most common cardiac arrhythmia atrial fibrillation (AF) may consist of conduction disorders, low-voltage areas, or fractionated potentials. High-density and resolution epicardial mapping (HDREM) approaches have been introduced to quantify and visualize electrophysiological properties of the atria. These approaches are essential for obtaining innovative insights into arrhythmogenic substrates and identifying novel targets for therapy. The aim of this review is to summarize and discuss the (1) contribution of HDREM studies to the knowledge on atrial arrhythmogenesis and (2) future applications of HDREM of atria in daily clinical practice.


  • Open Access

    Circulating ADAMTS13 Levels Are Associated with an Increased Occurrence of Obstructive Sleep Apnea

    by Mengling Huang, Sheng Liu, Shuang Liu, Wanwan Wen, Yu Ning, Yifan Jia, Yunxiao Yang, Xiaolu Jiao, Weiping Zheng, Ming Zhang

    Background and Aims. Obstructive sleep apnea (OSA) is strongly associated with obesity, metabolic diseases, coronary artery disease (CAD), stroke, hypertension, and other disorders. This study assessed the relationship between circulating a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13 (ADAMTS13) levels and the presence of OSA. Materials and Methods. This cross-sectional study included a total of 223 patients. We used a powerful high-throughput multiplexed immunobead-based assay to detect circulating levels of ADAMTS13. The associations between circulating ADAMTS13 levels and OSA were evaluated by multivariate logistic regression analysis. Results. Circulating ADAMTS13 levels were significantly elevated in patients with OSA compared with controls (0.8 vs. 2.7 μg/mL, respectively, ). After adjusting for confounding factors, circulating ADAMTS13 levels were significantly independently associated with the presence of OSA ( , 95% confidence interval (CI) =4.11–24.13, ). Furthermore, circulating ADAMTS13 levels showed discriminatory accuracy in assessing the presence of OSA (area under the curve: 0.87, 95% CI 0.81–0.93, ). Conclusion. Circulating ADAMTS13 levels were significantly correlated with the presence of OSA. ADAMTS13 may therefore function as a novel biomarker for monitoring the development and progression of OSA.


  • Thyroid hormones inhibit apoptosis of macrophage induced by oxidized low‐density lipoprotein

    by Yu Ning, Yifan Jia, Yunxiao Yang, Wanwan Wen, Mengling Huang, Sheng Liu, Yuejin Yang, Yugang Dong, Ming Zhang

    Increasing evidence suggests that hypothyroidism aggravates atherosclerosis. Macrophage apoptosis plays a significant role in the development of atherosclerotic plaque. We aimed to explore the effect of thyroid hormones on macrophage apoptosis induced by oxidized low‐density lipoprotein (oxLDL). Peripheral blood samples from 20 patients (normal group, hypothyroidism group, coronary artery disease [CAD] group, hypothyroidism + CAD group) were collected to perform messenger RNA microarray analysis. Bioinformatics analysis identified apoptosis and mitogen‐activated protein kinase (MAPK) signaling as differentially expressed pathways between CAD and hypothyroidism + CAD group. In vitro, thyroid hormones concentration‐dependently promoted cell survival and inhibited apoptosis in oxLDL‐treated RAW264.7 macrophages, along with elevated extracellular signal‐regulated kinases 1 and 2 (Erk1/2) phosphorylation. The STRING database showed an interaction of thyroid hormone receptor alpha1 (TRα1) and MAPK pathway. TRα1 knockdown increased cell apoptosis and decreased Erk1/2 phosphorylation. Erk1/2 inhibitor aggravated macrophage apoptosis. Moreover, thyroid hormones inhibited oxidative stress in oxLDL‐treated macrophages. The study indicates that thyroid hormones concentration‐dependently attenuate oxLDL‐induced macrophage apoptosis through activating TRα1‐Erk1/2 pathway and inhibiting oxidative stress, which implies a potential mechanism of hypothyroid‐accelerated atherosclerosis.


  • The clinical role of combined serum C1q and hsCRP in predicting coronary artery disease

    by Yifan Jia, Wanwan Wen, Yunxiao Yang, Mengling Huang, Yu Ning, Xiaolu Jiao, Sheng Liu, Yanwen Qin, Ming Zhang


  • Open Access

    Impact of chronic intermittent hypoxia on the long non‐coding RNA and mRNA expression profiles in myocardial infarction

    by Chaowei Hu, Jing Li, Yunhui Du, Juan Li, Yunyun Yang, Yifan Jia, Lu Peng, Yanwen Qin, Yongxiang Wei

    Chronic intermittent hypoxia (CIH) is the primary feature of obstructive sleep apnoea (OSA), a crucial risk factor for cardiovascular diseases. Long non‐coding RNAs (lncRNAs) in myocardial infarction (MI) pathogenesis have drawn considerable attention. However, whether CIH participates in the modulation of lncRNA profiles during MI is yet unclear. To investigate the influence of CIH on MI, cardiac damage was assessed by histology and echocardiography, and lncRNA and mRNA integrated microarrays were screened. MI mouse model showed myocardial hypertrophy, aggravated inflammation and fibrosis, and compromised left ventricle function under CIH. Compared with normoxia, 644 lncRNAs and 1084 differentially expressed mRNAs were identified following CIH for 4 weeks, whereas 1482 lncRNAs and 990 mRNAs were altered at 8 weeks. Strikingly, reoxygenation after CIH markedly affected 1759 lncRNAs and 778 mRNAs. Of these, 11 lncRNAs modulated by CIH were restored after reoxygenation and were validated by qPCR. The GO terms and KEGG pathways of genes varied significantly by CIH. lncRNA‐mRNA correlation further showed that lncRNAs, NONMMUT032513 and NONMMUT074571 were positively correlated with ZEB1 and negatively correlated with Cmbl. The current results demonstrated a causal correlation between CIH and lncRNA alternations during MI, suggesting that lncRNAs might be responsible for MI aggravation under CIH.


  • Open Access

    Usefulness of Cathepsin S to Predict Risk for Obstructive Sleep Apnea among Patients with Type 2 Diabetes

    by Wanwan Wen, Haili Sun, Yunxiao Yang, Yifan Jia, Fang Fang, Yanwen Qin, Ming Zhang, Yongxiang Wei

    Background. Obstructive sleep apnea (OSA) was highly prevalent in patients with type 2 diabetes (T2D). Cathepsin S (CTSS), a cysteine protease, is involved in the inflammatory activity in T2D and hypoxia conditions. The aim of the study was to evaluate whether CTSS could be involved in the inflammatory reaction of OSA in patients with T2D.Methods. We included 158 participants in this study matched for age, gender, and body mass index in 4 groups (control, non-OSA&T2D, OSA&non-T2D, and OSA&T2D). After overnight polysomnography, we collected the clinical data including anthropometrical characteristics, blood pressure, and fasting blood samples in the morning. Plasma CTSS concentration was evaluated using the human Magnetic Luminex Assay.Results. Compared with the control group, both the non-OSA&T2D group and the OSA&non-T2D group showed higher CTSS levels. Plasma CTSS expression was significantly increased in subjects with OSA&T2D compared to subjects with non-OSA&T2D. The OSA&T2D group had higher CTSS levels than the OSA&non-T2D group, but there were no statistically significant differences. Plasma CTSS levels showed significant correlation with the apnea-hypopnea index (AHI) (r=0.559,P<0.001) and plasma fasting blood glucose (r=0.427,P<0.001). After adjusting confounding factors, plasma CTSS levels were independently associated with the AHI (Beta: 0.386, 95% confidence intervals (CI): 21.988 to 57.781;P<0.001). Furthermore, we confirmed the higher pinpoint accuracy of plasma CTSS in the diagnosis of OSA (area under the curve: 0.868).Conclusions. Plasma CTSS expression was significantly elevated in the OSA&T2D group and was independently associated with the AHI; it could be a biomarker with a positive diagnostic value on diagnosing OSA among patients with T2D.


  • The association between circulating APRIL levels and severity of obstructive sleep apnea in Chinese adults

    by Wan-Wan Wen, Hai-Li Sun, Yun-Xiao Yang, Yi-Fan Jia, Meng-Ling Huang, Yun-Hui Du, Yan-Wen Qin, Fang Fang, Ming Zhang, Yong-Xiang Wei


  • TAK1-AMPK Pathway in Macrophages Regulates Hypothyroid Atherosclerosis

    by Yunxiao Yang, Yifan Jia, Yu Ning, Wanwan Wen, Yanwen Qin, Huina Zhang, Yunhui Du, Linyi Li, Xiaolu Jiao, Yunyun Yang, et al.

    Purpose Hypothyroidism (HT) is associated with accelerated atherosclerosis (AS). The efficacy of traditional strategies of hypothyroid AS remains controversial. Here, we aimed to deepen the understanding of the HT-induced acceleration of AS, to decrease the residual risk of coronary artery disease (CAD) and to find a new therapeutic target. Methods We collected peripheral venous blood samples from 20 patients and divided them into 4 groups, namely, the normal group, the HT group, the CAD group and the HT + CAD group. Then we performed mRNA microarray analysis and bioinformatics analysis to screen the differentially expressed genes and pathways, and we also conducted validations on ApoE knockout mice models and Raw264.7 cell models. Results In short, (1) in the analysis between the CAD group and the HT + CAD group, we found a total of 1218 differentially expressed genes, 11 upregulated pathways and 40 downregulated pathways. (2) We validated that patients with HT and CAD had a significantly decreased expression of MAP3K7 (encoding transforming growth factor-β-activated kinase 1, TAK1) gene than normal subjects. (3) In animal and cell experiments, we found the decreased expression of TAK1 and the reduced phosphorylation of AMP-activated protein kinase (AMPK) under the hypothyroid and atherosclerotic condition. (4) Changes in the expressions of TAK1 may affect the progression of AS. Conclusion Taken together, these data suggest that the accelerated AS in hypothyroid patients may be due to the suppression of TAK1-AMPK pathway in macrophages. This new finding may become a novel therapeutic target in hypothyroid AS.


  • CPAP is associated with decreased risk of AF recurrence in patients with OSA, especially those younger and slimmer: a meta-analysis

    by Yunxiao Yang, Yu Ning, Wanwan Wen, Yifan Jia, Xiaoyuan Chen, Mengling Huang, Jaskanwal Deep Sara, Yanwen Qin, Fang Fang, Huina Zhang, et al.

    Purpose Obstructive sleep apnea (OSA) is associated with the management of atrial fibrillation (AF). This manuscript aims to discuss the effects of continuous positive airway pressure (CPAP) in patients with rhythm control strategies and patients with different ages, weights and length of follow-up. Methods We searched Embase, PubMed, Cochrane, Web of Science and Ovid for relevant studies (from inception to 7 July 2019; English). The primary outcome was documented AF recurrence in CPAP users and nonusers. We assessed pooled data by use of a random-effects model. Results Nine prospective cohort studies with a total of 2134 participants met the inclusion criteria. Results showed that complementary CPAP therapy reduced AF recurrence (RR = 0.63; 95% CI, 0.56–0.72). In subgroup analyses, the benefits of CPAP were stronger in patients younger than 60 years old (< 60 years old: RR, 0.59; 95% CI, 0.50–0.68 vs. ≥ 60 years old: RR, 0.73; 95% CI, 0.59–0.91), with a body mass index (BMI) of less than 30 (< 30: RR, 0.53; 95% CI, 0.37–0.77 vs. ≥ 30: RR, 0.65; 95% CI, 0.55–0.77) or with less follow-up time (≤ 1 year: RR, 0.57; 95% CI, 0.42–0.79 vs. > 1 year: RR, 0.64; 95% CI, 0.53–0.78). Conclusions Complementary CPAP therapy reduces the risk of AF recurrence in OSA patients with rhythm control strategies. In addition to weight control and early AF intervention, CPAP compliance should be recommended along with periodic adjustments as necessary.


  • TNFRSF11B: A potential plasma biomarker for diagnosis of obstructive sleep apnea

    by Wan-Wan Wen, Yu Ning, Qing Zhang, Yun-Xiao Yang, Yi-Fan Jia, Hai-Li Sun, Yan-Wen Qin, Fang Fang, Ming Zhang, Yong-Xiang Wei